Press Releases
Payers Say Birth Control Mandate Will Increase Premiums, February 17, 2012
Payers Outlook for Lipitor Generic Strategy Not Rosy: Market Share Decline Coming Soon, December 2, 2011
Payers to Pharma: In Rheumatology, Innovations without Outcomes are Irrelevant, November 30, 2011
Real Endpoints Investment in Reimbursement Intelligence, November 15, 2011
Oncology Webinar Recap: High Cost of Cancer Drugs Forces Payors, Oncology Practices to Respond With New Payment Models, November 10, 2011
News and Articles
Payer Survey: Current Contraception Benefit Structure and Anticipated Impact of Mandated No-Cost Access for All Members , February 17, 2012
“What Managed Care Thinks of Pfizer And Its Lipitor Strategy” Forbes, December 2011
“Review of Strategies to Enhance Outcomes for Patients with Type 2 Diabetes: Payers’ Perspective” American Health and Drug Benefits, September/October 2011
“What Do Payers Want in Oncology Diagnostics? Insights From a National Survey of Top Commercial and Medicare Health Plans” American Health and Drug Benefits, August 2011
“Payers expect Provenge sales to stay flat” FiercePharma, August 2011
“Most Insurers Say Provenge Use Will Remain Flat” Pharmalot, August 2011
“Payers Insights Into Future Oncology Management” Oncology Business Review, July 2011
“Differing Views On The Eisai Breast Cancer Med” Pharmalot, July 2011
“NCCN Still Recommends Avastin For Breast Cancer” Pharmalot, July 2011
“Accountable Care Organizations: Implications for Oncologists” Value Based Cancer Care, June 2011
“Are Merck And J&J Fighting Over A Shrinking Pie?” , January 27th, 2011
“ASCO 2010: Payer Trends in Oncology Management and Latest Clinical Trial Data” American Health & Drug Benefits, August 2010
Publications
Biotechnology Entrepreneurship: From Science to Solutions – Chapter 9 “Roadmap to Reimbursement and Access”